Zurich Cantonal Bank
ORIC icon

Zurich Cantonal Bank’s Oric Pharmaceuticals ORIC Stock Holding History

Zurich Cantonal Bank’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,546
Closed -$135K – 3215
2025
Q4 		$135K Buy
+16,546
New +$190K ﹤0.01% 2339

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Zurich Cantonal Bank's ORIC Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 15,432 shares worth $196K. The stake represents ﹤0.01% of the portfolio and ranks #2251 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in ORIC as recently as Q1 2025.

Zurich Cantonal Bank first reported a position in ORIC in Q1 2021 and has held it in 10 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Zurich Cantonal Bank held 15,432 shares of Oric Pharmaceuticals worth $196K as of Q1 2026.
  • Oric Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2251 holding.
  • Zurich Cantonal Bank first reported a position in Oric Pharmaceuticals in Q1 2021 and has held it in 10 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.